Creative Medical Technology Announces Progress in Developing a Reproducible Clinical Grade of the Company’s ImmCelz® Product Read More »
BioRestorative Therapies Announces Selection of 10 Clinical Sites for its Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease Read More »
ExCellThera announces new publication showing its ECT-001 cell therapy improves transplant access for all patients Read More »
